Skip to content
← Back to this collection

PUBLICATIONS · 11134198

Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2001 Jan 1
First author
Rick O

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Rick O
      type
      Author
    2. name
      Bokemeyer C
      type
      Author
    3. name
      Beyer J
      type
      Author
    4. name
      Hartmann JT
      type
      Author
    5. name
      Schwella N
      type
      Author
    6. name
      Kingreen D
      type
      Author
    7. name
      Neureither S
      type
      Author
    8. name
      Metzner B
      type
      Author
    9. name
      Casper J
      type
      Author
    10. name
      Wandt H
      type
      Author
    11. name
      Hartmann F
      type
      Author
    12. name
      Schmoll HJ
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Rick O
      type
      Author
    2. name
      Bokemeyer C
      type
      Author
    3. name
      Beyer J
      type
      Author
    4. name
      Hartmann JT
      type
      Author
    5. name
      Schwella N
      type
      Author
    6. name
      Kingreen D
      type
      Author
    7. name
      Neureither S
      type
      Author
    8. name
      Metzner B
      type
      Author
    9. name
      Casper J
      type
      Author
    10. name
      Wandt H
      type
      Author
    11. name
      Hartmann F
      type
      Author
    12. name
      Schmoll HJ
      type
      Author
    bibliography ids
    1. nci-bib-25c7b90440a6880e4d34a4f1
    book metadata
    content sha256
    418b890c03f2b8cf11a45dc2f46262c5938156139bc4ff8592c9fed4da6dd870
    document type
    citation
    dois
    1. 10.1200/JCO.2001.19.1.81
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:11134198
    immutable id
    pubmed:11134198@418b890c03f2b8cf11a45dc2f46262c5938156139bc4ff8592c9fed4da6dd870
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    Source null
    issn print
    0732-183X
    issue
    1
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    81-8
    volume
    19
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      11134198
      provenance
      batch id
      30d2cd7affbbb92b6784
      provider
      NCBI PubMed ESummary
      record sha256
      03ba71746bfcc586b6eaa05f4744f1d84a6220166b4afe31c9a1900bc966f6d4
      response sha256
      ae7ed930f8b43c9e34eeae02f278f33f49c15777b81f742392c120eb64949120
      retrieved at
      2026-09-09T23:45:39.779418+00:00
      publication date
      display
      2001 Jan 1
      precision
      day
      year
      2001
      publication types
      1. Clinical Trial
      2. Clinical Trial, Phase II
      3. Journal Article
      4. Multicenter Study
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/11134198/
      title
      Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancer.

      Preserved source evidence · Not medical advice